MONASH University will receive $750,000 in new funding from the Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) as part of its ongoing collaboration with Certara's d3 Medicine offshoot.
With matching funding from Certara, the combined $1.5m will assist the Certara-Monash University Industry Fellowship Program to "identify and develop the next generation of industry-experienced drug development scientists" via training in clinical pharmacology, pharmacometrics and regulatory science".
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Oct 17
